Comparative short-term efficacy of upadacitinib versus tofacitinib for ulcerative colitis: a 24-week real-world study in Japan
Background/Aims Tofacitinib and upadacitinib are small-molecule compounds that inhibit the Janus kinase pathway for the treatment of refractory ulcerative colitis. Only a few reports have compared the efficacy and safety of these 2 drugs in real-world practice. We aimed to show our real-world eviden...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Korean Association for the Study of Intestinal Diseases
2026-01-01
|
| Collection: | Intestinal Research |
| Sujets: | |
| Accès en ligne: | http://irjournal.org/upload/pdf/ir-2024-00187.pdf |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|